Failure to recapture cardioprotection with high-dose atorvastatin in coronary artery bypass surgery: a randomised controlled trial

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Basic Research in Cardiology

• Publication date

  2011-08-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00395-011-0209-5PMID 21833652
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery.

  2011cited by this paper
• Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest

  2010cited by this paper
• Cardiac preconditioning for ischaemia: lost in translation

  2010cited by this paper
• Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations

  2010cited by this paper
• Simvastatin in contrast to postconditioning reduces infarct size in hyperlipidemic rabbits: possible role of oxidative/nitrosative stress attenuation

  2010cited by this paper
• Effects of atorvastatin on calcium-regulating proteins: a possible mechanism to repair cardiac dysfunction in spontaneously hypertensive rats

  2009cited by this paper
• 'Conditioning' the heart during surgery.

  2009cited by this paper
• Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial.

  2009influential reference
• Effect of atorvastatin on expression of IL-10 and TNF-alpha mRNA in myocardial ischemia-reperfusion injury in rats.

  2009cited by this paper
• Statins and cardioprotection--more than just lipid lowering?

  2009influential reference
• Coronary microembolization: from bedside to bench and back to bedside.

  2009cited by this paper
• Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold-blood cardioplegia: a randomised controlled trial

  2009cited by this paper
• Ischemic Postconditioning in Pigs: No Causal Role for Risk Activation

  2008cited by this paper
• Impact of Statin Use on Outcomes After Coronary Artery Bypass Graft Surgery

  2008cited by this paper
• Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30,000 patients.

  2008cited by this paper
• Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial.

  2008cited by this paper
• Effect of acute and chronic simvastatin treatment on post-ischemic contractile dysfunction in isolated rat heart.

  2008cited by this paper
• Universal definition of myocardial infarction.

  2007cited by this paper
• Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.

  2007cited by this paper
• Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection

  2007cited by this paper
• Aspirin before reperfusion blunts the infarct size limiting effect of atorvastatin.

  2007cited by this paper
• Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial.

  2007influential reference
• Universal definition of myocardial infarction.

  2007cited by this paper
• Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning

  2007cited by this paper
• Reduction of cerebral infarct size by the AT1-receptor blocker candesartan, the HMG-CoA reductase inhibitor rosuvastatin and their combination. An experimental study in rats.

  2006cited by this paper
• Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery.

  2006cited by this paper
• Augmentation of Myocardial Production of 15-Epi-Lipoxin-A4 by Pioglitazone and Atorvastatin in the Rat

  2006cited by this paper
• Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten?

  2005cited by this paper
• New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway.

  2004cited by this paper
• Randomized Trial of Atorvastatin for Reduction of Myocardial Damage During Coronary Intervention: Results From the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) Study

  2004cited by this paper
• Cardiac troponin T for prediction of short- and long-term morbidity and mortality after elective open heart surgery.

  2004cited by this paper
• Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway.

  2003cited by this paper
• Preprocedural Statin Medication Reduces the Extent of Periprocedural Non–Q-Wave Myocardial Infarction

  2002cited by this paper
• Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study.

  2001cited by this paper
• Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.

  2001cited by this paper
• Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.

  2001cited by this paper
• Inhibition of cholesterol synthesis by atorvastatin in homozygous familial hypercholesterolaemia.

  2000cited by this paper
• Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase.

  1998cited by this paper

• 2024 EACTS/EACTAIC/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery

  2025cites this paper
• 2024 EACTS/EACTAIC/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery

  2025cites this paper
• 2024 EACTS/EACTAIC/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery

  2025cites this paper
• Preoperative statin therapy for adults undergoing cardiac surgery.

  2024cites this paper
• Myocardial protection in cardiac surgery: a comprehensive review of current therapies and future cardioprotective strategies

  2024cites this paper
• Statin loading before coronary artery bypass grafting: a randomized trial.

  2023cites this paper
• Evaluation of High-Dose Atorvastatin Pretreatment Influence in Patients Preconditioning of Post Coronary Artery Bypass Graft Surgery: A Prospective Triple Blind Randomized Clinical Trial

  2021cites this paper
• Cardiac transcriptional and metabolic changes following thoracotomy

  2020cites this paper
• A review of myocardial ischaemia/reperfusion injury: Pathophysiology, experimental models, biomarkers, genetics and pharmacological treatment

  2020cites this paper
• Perioperative Statin Reloading in Cardiac Surgery: A Review

  2020cites this paper
• Does Statin Reloading Before Cardiac Surgery Improve Postoperative Outcomes?

  2017cites this paper
• Preoperative statin therapy for patients undergoing cardiac surgery.

  2016cites this paper
• Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery

  2016cites this paper
• Kardioprotektion beim herzchirurgischen Patienten

  2016cites this paper
• WITHDRAWN: Preoperative statin therapy for patients undergoing cardiac surgery.

  2016cites this paper
• Perioperative statin therapy in cardiac surgery: a meta-analysis of randomized controlled trials

  2016cites this paper
• Efficacy of Different Perioperative Statin Regimens on Protection Against Post-Coronary Artery Bypass Grafting Major Adverse Cardiac and Cerebral Events.

  2016cites this paper
• Redox signalling and cardioprotection: translatability and mechanism

  2015cites this paper
• Statin Recapture Therapy before Coronary Artery Bypass Grafting Trial: Rationale and study design of a multicenter, randomized, double-blinded controlled clinical trial.

  2015cites this paper
• Effect of preoperative oral pravastatin reload in systemic inflammatory response and myocardial damage after coronary artery bypass grafting. A pilot double-blind placebo-controlled study.

  2015cites this paper
• Impact of cardiovascular risk factors and medication use on the efficacy of remote ischaemic conditioning: post hoc subgroup analysis of a randomised controlled trial

  2015cites this paper
• Interaction of Risk Factors, Comorbidities, and Comedications with Ischemia/Reperfusion Injury and Cardioprotection by Preconditioning, Postconditioning, and Remote Conditioning

  2014cites this paper
• Pharmacologic Therapy That Simulates Conditioning for Cardiac Ischemic/Reperfusion Injury

  2014cites this paper
• Nutraceuticals and dyslipidaemia: Beyond the common therapeutics

  2014cites this paper
• Effets cliniques à court terme des statines initiées avant une intervention

  2013cites this paper
• Rosuvastatin Reloading before Cardiac Surgery with Cardiopulmonary Bypass

  2013cites this paper
• Activation of the homeostatic intracellular repair response during cardiac surgery.

  2013cites this paper
• [Short-term clinical effects of periprocedural statin therapy].

  2013cites this paper
• 2 Indicators of perioperative myocardial injury and infarction in cardiac surgery

  2012cites this paper
• Cardioprotection during cardiac surgery.

  2012cites this paper
• Current world literature.

  2012cites this paper